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Abstract 
Background: Duration of spinal anesthesia depends on the type of anesthetic agent, dosage and 
additive materials such as epinephrine, ephedrine and opioid. We compared the duration of spinal 
anesthesia with lidocaine 5% with or without epinephrine in addict and non-addict patients 
undergoing inferior limb fracture surgery. 
Methods: This single blinded randomized clinical trial was performed on 201 males (height ranged 
150-180 cm) who referred to the Shahid Bahonar Hospital of Kerman for the inferior limb fracture. 
Their physical class was matched to the American association standard class 1 and 2, and they were 
appropriate candidates for the spinal anesthesia. The addict or non-addict groups were each divided 
into two subgroups. 75 mg of 5% lidocaine was prescribed for one subgroup, and the other subgroup 
received 75 mg of 5% lidocaine plus 0.2 mg epinephrine. The level of primary anesthesia was elevated 
to T6. Duration of returning to the 4 primary sensory levels was measured since baseline. 
Findings: A significant increase in the duration of anesthesia level in both addict and non-addict 
patients receiving lidocaine plus epinephrine was observed compared to the subgroups receiving 
lidocaine alone (P < 0.01). Duration of decrease in sensory level in addict subgroups receiving 
lidocaine or lidocaine plus epinephrine was lower compared to non-addict patients (P < 0.001). In 
addict subgroup receiving lidocaine alone, a significant decrease was observed in the time needed for 
decrease in sensory level (P < 0.01). 
Conclusion: According to the results of this study, regardless of the anesthetic agent being used, 
duration of spinal anesthesia was shorter in addict patients compared to non-addict ones. Addition of 
epinephrine to lidocaine 5% increased the duration of spinal anesthesia in both addict and non-addict 
patients. 
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Introduction  
Sedation during and following the surgery is 
among the most important factors considered 
by anesthesiologists in surgical operations. 
Today, effective reduction of pain during local 
anesthesia and extending duration of this 
sedation have become possible for most 
patients through further use of pharmacology 
science and acquiring knowledge about 
application of the best method for anesthesia. 
Thus, anesthesiologists in the last two decades 
have been seeking for the combinations of 
medicines administered in spinal anesthesia to 
improve the quality and level of anesthesia and 
sedation during and following the operation. In 
addition, they have been seeking for the ways 
for reducing dosage of administered medicines, 
and consequently, lowering their adverse 
side-effects. Spinal anesthesia is one of the 
common techniques of sedation that reduces 
patient’s pain during surgical operations on 
lower limbs. Spinal anesthesia is a kind of 
blockage in spinal nerves which leads to 
symptomatic blockage, sensory analgesia, and 
motional blockage depending on dosage of 
local anesthetic medicine.1,2 In the absence of 
contraindication for spinal anesthesia, this 
method is widely used and adopted in many 
surgical interventions such as orthopedics, 
urology and midwifery.2 Other drugs added to 
local anesthetic medicine included epinephrine, 
phenylephrine, ephedrine, colloidine, narcotics 
and recently neostigmine that is an 
anticholinesterase, all result in lengthening of 
sedation and anesthesia duration.3  
Spinal anesthesia is sometimes preferred to 
general anesthesia in addicts depending on 
patient circumstances and anesthesiologist’s 
preference. As anesthetic method is modified, 
drugs such as ketamine, opioids, propofol, and 
benzodiazepines are prescribed for extending 
the sedation, unconsciousness, and patient’s 
comfort. Addition of each of aforementioned 
items will be followed by their own short-term 
or long-term complications. Pain threshold in 
addicts is lower than ordinary people who are 
not addicted to opium due to several reasons 
including change in function, sensitivity 
reduction, or decrease in opioids’ receptors. 
Nevertheless, they are more resistant against 
narcotics and analgesic drugs.4-7 
A couple of studies have attributed the 
reason for variation in production and 
performance of endogenous peptides to 
increased entry of exogenous narcotics; these 
studies have assumed this phenomenon as a 
factor for alleviation of pain threshold and 
increasing the response to stimulus in addicted 
people.6,8 Based on clinical findings, anesthesia 
or sedation duration is shorter in addicted 
patients compared to non-addicted ones6,8 and 
therefore, anesthesiologist is forced to apply 
supplementary drugs to alleviate patient’s pain 
throughout the surgical operation or to change 
the technique from spinal to general anesthesia. 
Change of anesthesia method and emergence of 
patient’s pain would give rise to patient’s 
anxiety and apprehension as well as problems 
associated with controlling the anesthesia 
scenario. Length of spinal anesthesia is 
specifically important both to avoid impairing 
surgeon’s performance due to early recovery 
prior to the end of operation and also in terms 
of start of pain feeling and patient’s irritability 
due to surgery when sedation is no longer 
working. Taking into account that prevalence of 
addiction to narcotics in Iran is 2.26% according 
to in the most recent report of United Nations 
Office on Drugs and Crime (UNODC) in 
August 2011, and that Iran ranks as the second 
country of the world in terms of narcotics 
consumption9 and because of lower pain 
threshold in addicted people, the current study 
was attempted to analyze duration of spinal 
anesthesia by 5% lidocaine with and without 
epinephrine in addicts and non-addicts who 
were candidates for orthopedic surgery of 
lower organs. 
 
Methods 
In a single-blinded randomized clinical trial 
during August 2010 to August 2011, 201 male 
patients admitted in Kerman Shahid Bahonar 
Hospital, Iran, were recruited. Inclusion criteria 
included male patients with age of 51-65 years 
and height range of 150-180 cm that reported no 
neurological disorders in the past and present 
time, and meanwhile, were content with spinal 
anesthesia. The participants had fractures in 
lower limbs and physical class of 1 and 2 
according to American Standard Association. 
Following initial examination and confirmation 
of absence of contraindications for spinal 
anesthesia and submission of consent forms, 
the patients were divided into two groups of 
addicted and non-addicted individuals. Each 
Duration of Spinal Anesthesia in Addicts and Non-addicts Mansourian et al. 
 
Addict Health, Summer & Autumn 2012; Vol 4, No 3-4. 97 
group was divided into two subgroups; one 
received 5% lidocaine and another one received 
5% lidocaine plus 0.2 mg epinephrine 
regardless of the operation type and duration. 
Addicted persons were determined based on 
their own statements. They were supposed to 
have taken narcotics at least for one year and 
withdrawal symptoms should have been 
clearly observed in the case of quitting. 
Non-addicted persons were expected not to 
have taken any narcotic drug during the last 
two years. Exclusion criteria were as follows: 
failure of primary sensory level to the sixth 
lumbar vertebral level or having higher 
anesthesia, body mass index above 35 and 
below 20 kg/m2, alcohol consumption, having 
any contraindication for performing spinal 
anesthesia, addiction period less than 1 year for 
addicted persons, and taking narcotics within 
the last two years for the non-addicted group. 
In operation room, after full monitoring of 
patient (blood pressure, pulse-oxymetry and 
electrocardiography), 500-750 ml of ringer 
serum were injected to all patients in 10-15 
minutes.  
With the patients in sitting position, 75 mg 
of lidocaine 5.0% in dextrose 7.5% were injected 
using sport needle number 34 through 3-4 
intervertebal space into the subarachnoid space 
of a group of patients under absolutely steril 
conditions. In the other group, 75 mg of 
lidocaine 5.0% and dextrose 7.5% plus 0.2 mg 
epinephrine at a rate of 0.2 ml/second were 
similarly injected. The patients were 
immediately allowed to lay back on the bed 
and primary sensory level was reached to the 
sixth lumbar vertebra level (in fact to the 
xiphoid level) by changing slope of operation 
room bed. Reduction of sensory level was 
checked every ten minutes by stimulating 
paient’s flanks with needle. Our criterion was  
recovery of 4 sensory levels compared to the 
primary sensory level (recovery of sensory 
perception level to navel periphery or tenth 
vertebrae). Duration of sensory level recovery 
was expressed as an integer multiplier of 10. 
 
Data Analysis 
Data of all four groups were registered as 1-4 
codes in a checklist and then. Using SPSS 
software version 17, the data were analyzed by 
Student’s t-test, one-way ANOVA, and chi-
square tests. P-value less than 5 percents was 
chosen as the significance limit. 
 
Results 
201 patients were recruited. In the non-addicted 
group, 51 individuals received lidocaine and 50 
persons were given lidocaine plus epinephrine. 
In the addicted group, 56 individuals received 
lidocaine and 44 persons were given lidocaine 
and epinephrine (Table 1).  
Among those who only received lidocaine, 8 
persons had 4 sensory levels reduction within 
10 minutes, 36 persons within 20 minutes, and 7 
persons within 7 minutes. In patients who were 
administered by lidocaine and epinephrine, 
nobody showed reduction in sensory 
perception level within the first ten minutes; 11 
and 39 persons had 4 sensory levels reduction 
within 20 and 30 minutes, respectively. 
Altogether, the four sensory levels reduction 
based on the primary sensory level were as 
follows: 8 persons within 10 minutes, 37 
persons within 20 minutes, and 46 persons 
within 30 minutes. Generally, duration of 
reduced sensory perception in the group 
receiving epinephrine plus lidocaine was longer 
than the value in the group who received 
lidocaine only (P = 0.003) (Table 1).  
In the addicted group who had received 
only lidocaine, duration of reduced sensory  
 
Table 1. Comparison of addicts and non-addict groups for durations of sensory level recovery in 10, 20, and 
30 minutes after spinal anesthesia 
  Duration (minutes)  
10 
n (%) 
20 
n (%) 
30 
n (%) 
Total 
n (%) 
Non-addict Lidocaine 8 (15.7) 36 (70.6) 7 (13.7) 51 (100) 
 Lidocaine + Epinephrine 0 11 (22.0) 39 (78.0) 50 (100) 
      
Addict Lidocaine 23 (38.9) 30 (55.6) 3 (5.6) 56 (100) 
 Lidocaine + Epinephrine 9 (21.4) 24 (52.4) 11 (29.2) 44 (100) 
      
Total  40 (19.3) 101 (50.3) 60 (30.5) 201 (100) 
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analogous to narcotic receptors in some areas of 
body, especially inside the spine in certain 
directions, particularly in terms of function and 
structure.12-14 Consequently, according to 
findings of the present study and taking into 
account the interference of opoid receptors and 
local sedatives, it seems that following 
declining adjustment phenomenon in narcotic 
receptors and increased tolerance to these 
drugs in addicted people, some degrees of 
resistance against effects of spinal anesthetic 
medicines might occur inside the body 
including spine. Lower pain threshold has been 
reported for addicted individuals compared to 
non-addicted people and low pain threshold is 
normally accompanied with exceeded tolerance 
against narcotic drugs.8,14 In the addicted 
people, this reduction in threshold of response 
to sensory stimuli and elevated tolerance 
against medicines might occur for local 
anesthetic medicines too. Overall, these 
variations could lead to shortening the duration 
of sensory blockage by local anesthetic 
medicines in addicts compared to the 
non-addicts. 
Duration of spinal anesthesia is a function of 
many variables. These variables include the 
method used for anesthesia, utilization of 
vascular tightening agents for reducing 
medicine removal from vicinity of the 
respective nerve, and amount of administered 
medicine because larger amount of medicine 
contributes to longer anesthesia duration.7 
Lidocaine is among the medicines extensively 
used for spinal anesthesia in under-waist 
surgical operations and duration of anesthesia 
by lidocaine is between 45 to 60 minutes while 
most orthopedic surgeries need longer time. 
Thus, the methods with least complication and 
longest possible anesthesia duration shall be 
applied. Adding vascular tightening agents 
such as epinephrine to the spinal anesthetic  
medicine is among the most recognized 
techniques. Epinephrine is capable of extending 
duration of lidocaine-induced spinal anesthesia 
for an additional 30 minutes.15,16 Yet, the major 
question of the current research was whether 
this increased duration of anesthesia by 
epinephrine is equal for all patients or not. The 
answer to this question was found by applying 
epinephrine together with lidocaine in addicts 
and non-addicts. Addition of 0.2 mg 
epinephrine to 5.0% lidocaine in spinal 
anesthesia resulted in extension of anesthetic 
duration in both addicted and non-addicted 
groups. Epinephrine is a symptomatic medicine 
and if added to lidocaine or any other spinal 
anesthetic drug with dosage of 0.1 to 0.4 mg, it 
will be able to lengthen anesthesia duration 
through contracting vessels of the injected area, 
and ultimately, gradual absorption and 
reducing removal of anesthetic substance.15,16 
The factors of age, weight, and height had no 
impact on anesthesia duration. However, 
duration of spinal anesthesia expectedly 
slightly decreased with increasing weight in 
both groups. 
 
Conclusion 
Findings of the current research indicated that 
the people addicted to opioids are more 
resistant against effects of local anesthetic 
medicines. Addition of epinephrine to 5.0% 
lidocaine leads to extended duration of spinal 
anesthesia in both addicted and non-addicted 
groups. Consequently, this finding shall be 
taken into account for addicts that need spinal 
anesthesia. Suitable solution shall be also 
devised to reduce the required dosage for such 
patients and also mitigating the side effects 
associated with further administration of local 
anesthetic medicines. 
Conflict of Interest: The authors have no 
conflict of interest. 
 
References 
1. Kokki H. Spinal blocks. Paediatr Anaesth 2012; 
22(1): 56-64. 
2. Brown D. Spinal, epidural, and caudal 
anesthesia, Anesthesia. In: Miller RD, editor. 
Miller's Anesthesia. Philadelphia, PA: Churchill 
Livingstone; 1994. 
3. Larson CP. Miller's Anesthesia. Anesth Analg; 
2010; 110(1): 263-5. 
4. Bovill JG. Mechanisms of actions of opioids and 
non-steroidal anti-inflammatory drugs. Eur J 
 Anaesthesiol Suppl 1997; 15: 9-15. 
5. Christie MJ. Cellular neuroadaptations to chronic 
opioids: tolerance, withdrawal and addiction. Br 
J Pharmacol 2008; 154(2): 384-96. 
6. Szeto HH, Soong Y, Wu D, Qian X, Zhao GM. 
Endogenous opioid peptides contribute to 
antinociceptive potency of intrathecal [Dmt1] 
DALDA. J Pharmacol Exp Ther 2003;  
305(2): 696-702. 
7. Wu HE, Thompson J, Sun HS, Leitermann RJ, 
Duration of Spinal Anesthesia in Addicts and Non-addicts Mansourian et al. 
 
100 Addict Health, Summer & Autumn 2012; Vol 4, No 3-4. 
Fujimoto JM, Tseng LF. Nonopioidergic 
mechanism mediating morphine-induced 
antianalgesia in the mouse spinal cord. J 
Pharmacol Exp Ther 2004; 310(1): 240-6. 
8. Christie MJ, Williams JT, North RA. Cellular 
mechanisms of opioid tolerance: studies in single 
brain neurons. Mol Pharmacol 1987; 32(5): 633-8. 
9. United Nations Office on drugs and crime. 
UNODC Executive Director visits drug 
treatment centre in Tehran. [Online]. 2011. 
Available from: URL:  
http://www.unodc.org/unodc/en/frontpage/2011/J
uly/unodc-executive-director-visits-drug-
treatment-centre-in-tehran.html. 
10. Labuz D, Chocyk A, Wedzony K, Toth G, 
Przewlocka B. Endomorphin-2, deltorphin II and 
their analogs suppress formalin-induced 
nociception and c-Fos expression in the rat spinal 
cord. Life Sci 2003; 73(4): 403-12. 
11. Yoburn BC, Gomes BA, Rajashekara V, Patel C, 
Patel M. Role of G(i)alpha2-protein in opioid 
tolerance and mu-opioid receptor downregulation  
in vivo. Synapse 2003; 47(2): 109-16. 
12. Hurley RW, Banfor P, Hammond DL. Spinal 
pharmacology of antinociception produced by 
microinjection of mu or delta opioid receptor 
agonists in the ventromedial medulla of the rat. 
Neuroscience 2003; 118(3): 789-96. 
13. Marchand F, Ardid D, Chapuy E, Alloui A, 
Jourdan D, Eschalier A. Evidence for an 
involvement of supraspinal delta- and spinal mu-
opioid receptors in the antihyperalgesic effect of 
chronically administered clomipramine in 
mononeuropathic rats. J Pharmacol Exp Ther 
2003; 307(1): 268-74. 
14. Chen SR, Pan HL. Antinociceptive effect of 
morphine, but not mu opioid receptor number, is 
attenuated in the spinal cord of diabetic rats. 
Anesthesiology 2003; 99(6): 1409-14. 
15. Chiu AA, Liu S, Carpenter RL, Kasman GS, 
Pollock JE, Neal JM. The effects of epinephrine 
on lidocaine spinal anesthesia: a cross-over 
study. Anesth Analg 1995; 80(4): 735-9. 
16. Leicht CH, Carlson SA. Prolongation of lidocaine 
spinal anesthesia with epinephrine and 
phenylephrine. Anesth Analg 1986; 65(4): 365-9. 
 ﻣﻘﺎﻟﻪ ﭘﮋوﻫﺸﻲ
  ، اﻳﺮانﻛﺮﻣﺎن، داﻧﺸﮕﺎه ﻋﻠﻮم ﭘﺰﺷﻜﻲ ﻛﺮﻣﺎنﮔﺮوه ﺑﻴﻬﻮﺷﻲ، ، دﺳﺘﻴﺎر -1
  ، اﻳﺮانﻛﺮﻣﺎناﺳﺘﺎدﻳﺎر، ﮔﺮوه ﺑﻴﻬﻮﺷﻲ، داﻧﺸﮕﺎه ﻋﻠﻮم ﭘﺰﺷﻜﻲ ﻛﺮﻣﺎن،  -2
  ، اﻳﺮانﻛﺮﻣﺎن، داﻧﺸﮕﺎه ﻋﻠﻮم ﭘﺰﺷﻜﻲ ﻛﺮﻣﺎن، ﻣﺮﻛﺰ ﺗﺤﻘﻴﻘﺎت ﻋﻠﻮم اﻋﺼﺎباﺳﺘﺎدﻳﺎر،  -3
  ، اﻳﺮانﻛﺮﻣﺎن، داﻧﺸﮕﺎه ﻋﻠﻮم ﭘﺰﺷﻜﻲ ﻛﺮﻣﺎن، ﻣﺮﻛﺰ ﺗﺤﻘﻴﻘﺎت ﻋﻠﻮم اﻋﺼﺎب، ﻣﺤﻘﻖ ﭘﮋوﻫﺸﮕﺮ -4
   ri.ca.umk@inabahs :liamE  ﻣﺤﻤﺪ ﺷﻌﺒﺎﻧﻲدﻛﺘﺮ  :ﻣﺴﺆول  ﻧﻮﻳﺴﻨﺪه
 
 101 .4-3 oN ,4 loV ;2102 nmutuA & remmuS ,htlaeH tciddA
ﻧﻔﺮﻳﻦ در  ﻟﻴﺪوﻛﺎﻳﻴﻦ ﻫﻤﺮاه ﺑﺎ اﭘﻲ ﺣﺴﻲ ﻧﺨﺎﻋﻲ ﺑﺎ ﻟﻴﺪوﻛﺎﻳﻴﻦ و ﻣﻘﺎﻳﺴﻪ ﻣﺪت زﻣﺎن ﺑﻲ
  ﺑﻴﻤﺎران ﻣﻌﺘﺎد و ﻏﻴﺮ ﻣﻌﺘﺎد ﺗﺤﺖ ﺟﺮاﺣﻲ ارﺗﻮﭘﺪي اﻧﺪام ﺗﺤﺘﺎﻧﻲ
  
  4دﻳﻮﺳﺎﻻر ﻛﻮروس ،3ﺷﻌﺒﺎﻧﻲ ﻣﺤﻤﺪدﻛﺘﺮ  ،2زاده ﻋﺴﻜﺮ ﻣﺤﻤﺪدﻛﺘﺮ  ،1ﻣﻨﺼﻮرﻳﺎن اﻓﺸﻴﻦدﻛﺘﺮ 
  
  
  ﭼﻜﻴﺪه
ﻧﻔﺮﻳﻦ، اﻓﺪرﻳﻦ و  ﺣﺴﻲ دﻫﻨﺪه، ﻣﻘﺪار دارو و اﺿﺎﻓﻪ ﻛﺮدن داروﻫﺎﻳﻲ ﻣﺎﻧﻨﺪ اﭘﻲ ﺣﺴﻲ ﻧﺨﺎﻋﻲ ﺑﻪ ﻧﻮع داروي ﺑﻲ ﻣﺪت ﺑﻲ: ﻣﻘﺪﻣﻪ
ﻧﻔﺮﻳﻦ در  اﭘﻲدرﺻﺪ ﺑﺎ و ﺑﺪون  5ﺣﺴﻲ ﻧﺨﺎﻋﻲ ﺑﺎ ﻟﻴﺪوﻛﺎﻳﻴﻦ  ﻫﺪف از اﻳﻦ ﻣﻄﺎﻟﻌﻪ، ﻣﻘﺎﻳﺴﻪ ﻣﺪت زﻣﺎن ﺑﻲ. ﻣﺨﺪر واﺑﺴﺘﻪ اﺳﺖ
  .ﺑﻴﻤﺎران ﻣﻌﺘﺎد و ﻏﻴﺮ ﻣﻌﺘﺎد ﻣﺒﺘﻼ ﺑﻪ ﺷﻜﺴﺘﮕﻲ اﻧﺪام ﺗﺤﺘﺎﻧﻲ ﺑﻮد
و  1 ﻣﺘﺮ و ﺑﺎ ﻛﻼس ﻓﻴﺰﻳﻜﻲ ﺳﺎﻧﺘﻲ 051-081ﺑﻴﻤﺎر ﻣﺮد ﺑﺎ ﻗﺪ  102ﻣﻄﺎﻟﻌﻪ ﺣﺎﺿﺮ ﺑﻪ ﺻﻮرت ﻛﺎرازﻣﺎﻳﻲ ﺑﺎﻟﻴﻨﻲ ﺑﺮ روي  :ﻫﺎ روش
ﻳﻚ ﺳﻮ ﻛﻮر در ﺑﻴﻤﺎران ﻣﺮاﺟﻌﻪ ﻛﻨﻨﺪه ﺑﻪ  ﮔﻴﺮي ﺑﻪ ﺻﻮرت ﺗﺼﺎدﻓﻲ و ﻧﻤﻮﻧﻪ. ﻣﻨﻄﺒﻖ ﺑﺎ اﺳﺘﺎﻧﺪارد اﻧﺠﻤﻦ آﻣﺮﻳﻜﺎ ﺻﻮرت ﮔﺮﻓﺖ 2
ﺣﺴﻲ ﻧﺨﺎﻋﻲ ﺑﻮدﻧﺪ، اﻧﺠﺎم  ﻫﻮﺷﻲ ﺑﻪ روش ﺑﻲ ﺑﻴﻤﺎرﺳﺘﺎن ﺷﻬﻴﺪ ﺑﺎﻫﻨﺮ ﻛﺮﻣﺎن ﻛﻪ دﭼﺎر ﺷﻜﺴﺘﮕﻲ اﻧﺪام ﺗﺤﺘﺎﻧﻲ ﺑﻮده و داوﻃﻠﺐ ﺑﻲ
درﺻﺪ و  5ﮔﺮم ﻟﻴﺪوﻛﺎﻳﻴﻦ  ﻣﻴﻠﻲ 57ﺑﻪ ﻳﻚ زﻳﺮ ﮔﺮوه، . ﻫﺮ ﻛﺪام از دو ﮔﺮوه ﻣﻌﺘﺎد و ﻏﻴﺮ ﻣﻌﺘﺎد ﺑﻪ دو زﻳﺮ ﮔﺮوه ﺗﻘﺴﻴﻢ ﺷﺪﻧﺪ. ﺷﺪ
ﻧﻔﺮﻳﻦ ﺗﺰرﻳﻖ ﺷﺪ و ﺳﻄﺢ ﺣﺴﻲ اوﻟﻴﻪ ﺑﻪ ﻣﻬﺮه ﺷﺸﻢ  ﮔﺮم اﭘﻲ ﻣﻴﻠﻲ 0/2درﺻﺪ ﻫﻤﺮاه ﺑﺎ  5ﮔﺮم ﻟﻴﺪوﻛﺎﻳﻴﻦ  ﻣﻴﻠﻲ 57ﮔﺮوه دﻳﮕﺮ 
  .ﮔﻴﺮي ﮔﺮدﻳﺪ ﺳﻄﺢ ﺣﺴﻲ از ﺣﺲ اوﻟﻴﻪ اﻧﺪازه 4ﻣﺪت زﻣﺎن ﺑﺮﮔﺸﺖ . رﺳﺎﻧﺪه ﺷﺪ (cicarohT)ﭘﺸﺘﻲ 
ﻧﻔﺮﻳﻦ ﺑﻪ ﻟﻴﺪوﻛﺎﻳﻴﻦ  ﻫﺎي ﻣﻌﺘﺎد و ﻏﻴﺮ ﻣﻌﺘﺎد ﻛﻪ اﭘﻲ ﺣﺴﻲ در ﮔﺮوه داري در ﻣﺪت زﻣﺎن ﻛﺎﻫﺶ ﺳﻄﺢ ﺑﻲ اﻓﺰاﻳﺶ ﻣﻌﻨﻲ :ﻫﺎ ﻳﺎﻓﺘﻪ
ﻣﺪت زﻣﺎن ﻛﺎﻫﺶ ﺳﻄﺢ (. P < 0/10)اﺿﺎﻓﻪ ﺷﺪه ﺑﻮد در ﻣﻘﺎﻳﺴﻪ ﺑﺎ ﮔﺮوﻫﻲ ﻛﻪ ﻟﻴﺪوﻛﺎﻳﻴﻦ ﺑﻪ ﺗﻨﻬﺎﻳﻲ ﮔﺮﻓﺘﻪ ﺑﻮدﻧﺪ، ﻣﺸﺎﻫﺪه ﺷﺪ 
ﻧﻔﺮﻳﻦ درﻳﺎﻓﺖ ﻛﺮده ﺑﻮدﻧﺪ، ﻧﺴﺒﺖ ﺑﻪ ﮔﺮوه ﻏﻴﺮ ﻣﻌﺘﺎد  ﻟﻴﺪوﻛﺎﻳﻴﻦ ﻫﻤﺮاه ﺑﺎ اﭘﻲﺣﺴﻲ در ﮔﺮوه ﻣﻌﺘﺎد ﭼﻪ ﻟﻴﺪوﻛﺎﻳﻴﻦ ﺑﻪ ﺗﻨﻬﺎﻳﻲ و ﻳﺎ 
در اﻓﺮاد ﻣﻌﺘﺎد ﮔﺮوه درﻳﺎﻓﺖ ﻛﻨﻨﺪه ﻟﻴﺪوﻛﺎﻳﻴﻦ ﺑﻪ ﺗﻨﻬﺎﻳﻲ ﻧﺴﺒﺖ ﺑﻪ ﮔﺮوه ﻟﻴﺪوﻛﺎﻳﻴﻦ (. P < 0/100)داري ﻧﺸﺎن داد  ﻛﺎﻫﺶ ﻣﻌﻨﻲ
  (.P < 0/10)داري ﻣﺸﺎﻫﺪه ﺷﺪ  ﻧﻔﺮﻳﻦ در ﻣﺪت زﻣﺎن ﻛﺎﻫﺶ ﺳﻄﺢ ﺣﺴﻲ ﻛﺎﻫﺶ ﻣﻌﻨﻲ ﻫﻤﺮاه ﺑﺎ اﭘﻲ
ﺣﺴﻲ دﻫﻨﺪه ﻧﺨﺎﻋﻲ، ﻣﺪت زﻣﺎن  ﺗﻮان ﺣﺪس زد ﻛﻪ ﺻﺮف ﻧﻈﺮ از ﻧﻮع داروي ﺑﻲ ﺑﺎ ﺗﻮﺟﻪ ﺑﻪ ﻣﻄﺎﻟﻌﻪ ﺣﺎﺿﺮ، ﻣﻲ :ﮔﻴﺮي ﻧﺘﻴﺠﻪ
ﺣﺴﻲ  درﺻﺪ در اﻧﺠﺎم ﺑﻲ 5ﻧﻔﺮﻳﻦ ﺑﻪ ﻟﻴﺪوﻛﺎﻳﻴﻦ  ﺗﺮ از اﻓﺮاد ﻏﻴﺮ ﻣﻌﺘﺎد اﺳﺖ و اﻓﺰودن اﭘﻲ ﺣﺴﻲ ﻧﺨﺎﻋﻲ در اﻓﺮاد ﻣﻌﺘﺎد ﻛﻮﺗﺎه ﺑﻲ
  .ﺷﺪﺣﺴﻲ ﻧﺨﺎﻋﻲ در ﻫﺮ دو ﮔﺮوه ﻣﻌﺘﺎد و ﻏﻴﺮ ﻣﻌﺘﺎد  ﻲﻧﺨﺎﻋﻲ ﺑﺎﻋﺚ اﻓﺰاﻳﺶ ﻣﺪت زﻣﺎن ﺑ
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